Author

Peter Sasieni

SIMPLE CYTOSPONGE-BIOMARKER TECHNOLOGY TO PRIORITIZE ENDOSCOPIC BARRETT’S ESOPHAGUS SURVEILLANCE
SIMPLE CYTOSPONGE-BIOMARKER TECHNOLOGY TO PRIORITIZE ENDOSCOPIC BARRETT’S ESOPHAGUS SURVEILLANCE

Peter Sasieni  et al.

RANGE OF PATHOLOGIES DIAGNOSED AMONG A SCREENING POPULATION OF PATIENTS WITH REFLUX DISEASE: RESULTS FROM THE CYTOSPONGE-BEST3 TRIAL
RANGE OF PATHOLOGIES DIAGNOSED AMONG A SCREENING POPULATION OF PATIENTS WITH REFLUX DISEASE: RESULTS FROM THE CYTOSPONGE-BEST3 TRIAL

Peter Sasieni  et al.

Item 1 - 2 / 2
1